A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Cancer Therapy
DOI:
10.1126/science.285.5434.1733
Publication Date:
2002-07-27T09:37:20Z
AUTHORS (7)
ABSTRACT
Chemotherapy and radiation therapy for cancer often have severe side effects that limit their efficacy. Because these are in part determined by p53-mediated apoptosis, temporary suppression of p53 has been suggested as a therapeutic strategy to prevent damage normal tissues during treatment p53-deficient tumors. To test this possibility, small molecule was isolated its ability reversibly block p53-dependent transcriptional activation apoptosis. This compound, pifithrin-alpha, protected mice from the lethal genotoxic stress associated with anticancer without promoting formation Thus, inhibitors may be useful drugs reducing other types induction.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (1043)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....